Discover
BIIB
Biogen Inc.
205.16
1 x 205.13
1 x 205.28
bid
ask
-
1.97
0.95%
01:41 PM
timesize
| Ytd | 16.57% | |
| 1y | 60.28% |
203.53
day range
207.46
128.00
52 week range
216.63
| Open | 206.45 | Prev Close | 207.13 | Low | 203.53 | High | 207.46 | Mkt Cap | 30.33B |
| Vol | 324.37K | Avg Vol | 1.25M | EPS | 15.84 | P/E | 12.96 | Forward P/E | 12.52 |
| Beta | 0.17 | Short Ratio | 3.87 | Inst. Own | 96.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 202.14 | 200-d Avg | 185.20 | 1yr Est | 235.32 |
| Income Statement | |||
| Total Revenue | 2.74B | ||
| Revenues (USD) | 2.74B | ||
| Cost of Revenue | 776.90M | ||
| Gross Profit | 1.96B | ||
| Operating Expenses | 1.83B | ||
| Research and Development Expense | 529.60M | ||
| Selling, General and Administrative Expense | 709.70M | ||
| Operating Income | 132.40M | ||
| Income Tax Expense | 34.90M | ||
| Net Income | 97.50M | ||
| Net Income Common Stock | 97.50M | ||
| Net Income Common Stock (USD) | 97.50M | ||
| Consolidated Income | 97.50M | ||
| Earnings per Basic Share | 0.66 | ||
| Earnings per Basic Share (USD) | 0.66 | ||
| Earnings per Diluted Share | 0.66 | ||
| Earning Before Interest & Taxes (EBIT) | 132.40M | ||
| Earning Before Interest & Taxes (USD) | 132.40M | ||
| Weighted Average Shares | 147.70M | ||
| Weighted Average Shares Diluted | 148.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.29B | ||
| Cash and Equivalents (USD) | 1.29B | ||
| Investments | 831.80M | ||
| Investments Non-Current | 831.80M | ||
| Trade and Non-Trade Receivables | 2.40B | ||
| Current Assets | 7.31B | ||
| Property, Plant & Equipment Net | 3.24B | ||
| Total Assets | 32.09B | ||
| Debt Current | 800.00M | ||
| Total Debt | 8.36B | ||
| Current Liabilities | 3.92B | ||
| Debt Non-Current | 7.56B | ||
| Total Liabilities | 13.24B | ||
| Accumulated Retained Earnings (Deficit) | 20.97B | ||
| Accumulated Other Comprehensive Income | -127.70M | ||
| Shareholders Equity | 18.85B | ||
| Shareholders Equity (USD) | 18.85B | ||
| Assets Non-Current | 24.78B | ||
| Total Debt (USD) | 8.36B | ||
| Goodwill and Intangible Assets | 20.51B | ||
| Inventory | 2.38B | ||
| Liabilities Non-Current | 9.32B | ||
| Trade and Non-Trade Payables | 403.90M | ||
| Tax Assets | 202.10M | ||
| Tax Liabilities | 1.03B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 236.10M | ||
| Net Cash Flow from Financing | 1.30B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.09B | ||
| Capital Expenditure | -40.90M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -5.07B | ||
| Issuance (Repayment) of Debt Securities | 1.30B | ||
| Net Cash Flow from Investing | -3.84B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.37B | ||
| Net Cash Flow from Operations | 448.90M | ||
| Effect of Exchange Rate Changes on Cash | -3.40M | ||
| Share Based Compensation | 77.40M | ||